Cercano Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $347K | Hold |
780
| – | – | 0.01% | 120 |
|
|
2025
Q1 | $378K | Hold |
780
| – | – | 0.01% | 113 |
|
|
2024
Q4 | $314K | Sell |
780
-62,577
| -99% | -$25.2M | 0.01% | 139 |
|
|
2024
Q3 | $29.5M | Sell |
63,357
-7,602
| -11% | -$3.54M | 0.7% | 38 |
|
|
2024
Q2 | $33.3M | Buy |
70,959
+426
| +0.6% | +$200K | 0.89% | 34 |
|
|
2024
Q1 | $29.5M | Buy |
70,533
+311
| +0.4% | +$130K | 0.82% | 35 |
|
|
2023
Q4 | $28.6M | Hold |
70,222
| – | – | 0.94% | 29 |
|
|
2023
Q3 | $24.4M | Hold |
70,222
| – | – | 0.87% | 33 |
|
|
2023
Q2 | $24.7M | Buy |
70,222
+5,101
| +8% | +$1.8M | 0.86% | 31 |
|
|
2023
Q1 | $20.5M | Sell |
65,121
-3,329
| -5% | -$1.05M | 0.82% | 25 |
|
|
2022
Q4 | $19.8M | Buy |
+68,450
| New | +$19.8M | 0.8% | 27 |
|